Precision behavioral medicine: Implications of genetic and genomic discoveries for behavioral weight loss treatment
- PMID: 30394782
- PMCID: PMC6220707
- DOI: 10.1037/amp0000253
Precision behavioral medicine: Implications of genetic and genomic discoveries for behavioral weight loss treatment
Abstract
This article reviews the concept of precision behavioral medicine and the progress toward applying genetics and genomics as tools to optimize weight management intervention. We discuss genetic, epigenetic, and genomic markers, as well as interactions between genetics and the environment as they relate to obesity and behavioral weight loss to date. Recommendations for the conditions under which genetics and genomics could be incorporated to support clinical decision-making in behavioral weight loss are outlined and illustrative scenarios of how this approach could improve clinical outcomes are provided. It is concluded that there is not yet sufficient evidence to leverage genetics or genomics to aid the treatment of obesity but the foundations are being laid. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
Figures
References
-
- Andreasen CH, Stender-Petersen KL, Mogensen MS, Torekov SS, Wegner L, Andersen G, … Hansen T. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes. 2008;57(1):95–101. - PubMed
-
- Aronica L, Levine AJ, Brennan K, Mi J, Gardner C, Haile RW, Hitchins MP. A systematic review of studies of DNA methylation in the context of a weight loss intervention. Epigenomics. 2017;9(5):769–787. - PubMed
-
- Bouchard C, Tremblay A, Despres JP, Theriault G, Nadeau A, Lupien PJ, … Fournier G. The response to exercise with constant energy intake in identical twins. Obesity Research. 1994;2(5):400–410. - PubMed